WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007010242) USE OF A NORADRENERGIC AGONIST, E.G. GUANFACINE, FOR THE TREATMENT OF COGNITIVE DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/010242    International Application No.:    PCT/GB2006/002669
Publication Date: 25.01.2007 International Filing Date: 18.07.2006
IPC:
A61K 31/165 (2006.01), A61P 25/28 (2006.01)
Applicants: IMPERIAL COLLEGE INNOVATIONS LIMITED [GB/GB]; Electrical and Electronic Engineering Building, Level 12, Imperial College, Exhibition Road, London SW7 2AZ (GB) (For All Designated States Except US).
HUSAIN, Masud [GB/GB]; (GB) (For US Only).
PARTON, Andrew, David [GB/GB]; (GB) (For US Only).
MALHOTRA, Paresh, Arjun [GB/GB]; (GB) (For US Only)
Inventors: HUSAIN, Masud; (GB).
PARTON, Andrew, David; (GB).
MALHOTRA, Paresh, Arjun; (GB)
Agent: LEE, Nicholas, John; Kilburn & Strode, 20 Red Lion Street, London WC1R 4PJ (GB)
Priority Data:
0514687.3 18.07.2005 GB
0516373.8 09.08.2005 GB
Title (EN) USE OF A NORADRENERGIC AGONIST, E.G. GUANFACINE, FOR THE TREATMENT OF COGNITIVE DISORDERS
(FR) UTILISATION D'UN AGONISTE NORADRENERGIQUE, A SAVOIR, LA GUANFACINE POUR LE TRAITEMENT DE TROUBLES COGNITIFS
Abstract: front page image
(EN)The present invention relates to the use of a noradrenergic agonist for the treatment of a patient with a cognitive disorder resulting from acquired brain damage, wherein the cognitive disorder includes, for example, hemi-spatial neglect.
(FR)La présente invention concerne l'utilisation d'un agoniste noradrénergique dans le traitement d'un patient souffrant d'un trouble cognitif provenant d'un accident cérébral acquis, ledit trouble cognitif comprenant, par exemple, une hémi-négligence spatiale.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)